FDA Proposes Ban on Brominated Vegetable Oil Due to Health Risks

FDA Proposes Ban on Brominated Vegetable Oil Due to Health Risks

FDA Proposes Nationwide Ban on Brominated Vegetable Oil (BVO) in Food Additives, Continues Safety Assessment of Chemicals

FDA to Nationwide Ban Brominated Vegetable Oil (BVO) in Food

Novo Nordisk Launches Wegovy in South Africa One in Two Adults Faces Obesity as GLP-1 Drug Competition Heats Up

Eli Lilly Strikes $1.3 Billion AI Deal with Superluminal for Next-Gen Obesity Drugs Targets GPCR Breakthrough

Eli Lilly to Raise UK Mounjaro Price 170 Percent Monthly Cost Jumps from £122 to £330

FDA Approves Precigen’s Papzimeos Immunotherapy 51 Percent of RRP Patients Avoid Surgery for One Year

Pfizer Lifts 2025 Profit Forecast After Q2 Earnings Beat Sales Hit $14.65 Billion Shares Jump 2.8 Percent

Sandoz Set to Slash Canadian Weight-loss Drug Prices by Up to 70 Percent Generics Could Expand Patient Access

Syndax Q2 Net Loss Widens to $71.8 Million Despite 43 Percent Revenue Surge and New Drug Momentum